North America Drug Delivery Systems Market to Reach US$ 572,453.0 Mn at CAGR of 7.4% in 2027 | The Insight Partners
Medical Device North America Drug Delivery Systems...

North America Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country

Publication Month: Jun 2019 | Report Code: TIPRE00005752 | No. of Pages: 249 | Category: Medical Device | Status: Published

The North America human drug delivery systems market is expected to reach US$ 1,074,679.7 Mn in 2027 from US$ 572,453.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.

 

Key factors that are driving the growth of the market are rising need for medication among the populace, extensive research and developments projects undertaken by various market players to sustain their leadership in the market leading to launch of new and innovative products as well as a well-established pharmaceutical and medical device industry in the region.

 

Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to the increasing prevalence of the chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases. Also, cancer is one of the leading cause of death in the North America region. Furthermore, the American Cancer Society (ACS) estimated that in 2018, approximately 1,735,350 new cancer cases were diagnosed. Targeted drug delivery system (TDDS) is a system, which delivers the drug in a controlled manner at a preselected biosite. Diabetes is a life-threatening chronic disease with no specialized cure. Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. For instance, according to the International Diabetes Federation (IDF), in 2017, a number of people with diabetes in North America was approximately 46 million, which is expected to reach 62 million in 2045. Thus, the increasing number of patients suffering from one or more chronic diseases is expected to boost the growth of drug delivery devices market over the coming years.

 

The US drug delivery systems market is expected to grow at the highest rate during the forecast period. The growth of this market is primarily driven by increasing prevalence of chronic diseases like diabetes, asthma, and others, a growing number of product launches by key players; and increasing use of drug delivery systems for disease management. The market for drug delivery systems in the US region is expected to reach US$ 741,528.96 Mn in 2027 from US$ 388,359.24 Mn in 2018. The growth rate of the market in the region is estimated to be 7.6% during the forecast period.

NORTH AMERICA DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION

By Route of Administration

  • Oral
    • Solid Oral Drugs
    • Liquid Oral Drugs
    • Semi-solid Oral Drugs
  • Transmucosal
    • Pulmonary Drug Delivery
      • In-metered Dose Inhalers
      • Dry Powder Inhalers
      • Nebulizers
    • Nasal Drug Delivery
      • Nasal Sprays
      • Nasal Drops
      • Nasal Gels
    • Buccal Drug Delivery
    • Sublingual Drug Delivery
    • Rectal Transmucosal Drug delivery
    • Vaginal Transmucosal Drug Delivery
  • Injectable
    • Conventional Injection Devices
    • Self-Injection Devices
      • Needle Free Injectors
      • Pen Injectors
      • Wearable Injectors
  • Topical
    • Semi-solid Topical Drug Delivery Formulations
    • Liquid Topical Drug Delivery Formulations
    • Solid Topical Drug Delivery Formulations
    • Transdermal Patches
    • Transdermal Gels
    • Others
  • Implantable
    • Active Implantable
    • Passive Implantable
  • Ocular
    • Eye Drops & Sprays
    • Gels & Ointments
    • Ocular Inserts
  • Drug Coated Contact Lenses

NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION

By Application

  • Hospital & Clinics
  • Home Care Settings
  • Others

NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies 

By Country

  • U.S
  • Canada
  • Mexico

Companies Mentioned

  • BD
  • Novo Nordisk A/S
  • 3M
  • Boston Scientific Corporation
  • Bausch Health Companies Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim
  • Novartis AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.

PART 1.       iNTRODUCTION

1.1            Scope of the Study

1.2            The Insight Partners Research Report Guidance

PART 2.       North America Drug delivery systems Market – Key takeaways

PART 3.       North America Drug delivery systems market – market landscape

3.1            overview

3.2            market segmentation

3.2.1          North America Drug Delivery Systems Market – By Route of Administration

3.2.2          North America Drug Delivery Systems Market – By Application

3.2.3          North America Drug Delivery Systems Market – By Distribution Channel

3.2.4          North America Drug Delivery Systems Market – By Country

3.3            PEST Analysis

PART 4.       North America Drug delivery systems market- Key Market Dynamics

4.1            Key Market Drivers

4.1.1          Rising Number of Patients Suffering with Chronic Diseases

4.1.2          Increasing Adoption Towards Non-Invasive Drug Delivery Systems

4.2            Key Market Restraints

4.2.1          Product Recalls for Drug Delivery Systems

4.3            Key Market Opportunities

4.3.1          Rising Compliance of Patients

4.4            future Trends

4.4.1          Introduction of Novel Drug Delivery Systems

4.5            Impact analysis

PART 5.       Drug delivery systems market – North America Analysis

5.1            North America Drug delivery systems market Revenue Forecasts and Analysis

5.2            Market positioning

5.3            PERFORMANCE OF KEY PLAYERS

PART 6.       drug Delivery systems Market – North America Regulatory Scenario

6.1            north america

6.1.1          US

6.1.2          Canada

6.1.3          Mexico

PART 7.       North America drug delivery systems market Analysis – By Route of Administration

7.1            Overview

7.2            NORTH AMERICA drug delivery systems MARKET, BY Route of Administration, 2018 & 2027 (%)

7.3            North America Drug delivery systems market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

7.4            oral drug delivery Market

7.4.1          Overview

7.4.2          Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3          Solid Oral Drugs Market

7.4.3.1      Overview

7.4.3.2      Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3.3      SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

7.4.4          Liquid Oral Drugs Market

7.4.4.1      Overview

7.4.4.2      Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4.3      LIQUID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

7.4.5          Semi-solid Oral Drugs Market

7.4.5.1      Overview

7.4.5.2      Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)

7.4.5.3      SEMI-SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

7.5            transmucosal drug delivery Market

7.5.1          Overview

7.5.2          Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.3          Pulmonary Drug Delivery Market

7.5.3.1      Overview

7.5.3.2      Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.3.3      PULMONARY DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

7.5.3.4      In-metered Dose Inhalers Market

7.5.3.4.1       Overview

7.5.3.4.2       In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

7.5.3.5      Dry Powder Inhalers Market

7.5.3.5.1       Overview

7.5.3.5.2       Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

7.5.3.6      Nebulizers Market

7.5.3.6.1       Overview

7.5.3.6.2       Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)

7.5.4          Nasal Drug Delivery Market

7.5.4.1      Overview

7.5.4.2      Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.4.3      Nasal Spray Market

7.5.4.3.1       Overview

7.5.4.3.2       Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)

7.5.4.4      Nasal Drops Market

7.5.4.4.1       Overview

7.5.4.4.2       Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)

7.5.4.5      Nasal Gel Market

7.5.4.5.1       Overview

7.5.4.5.2       Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)

7.5.5          Buccal Drug Delivery Market

7.5.5.1      Overview

7.5.5.2      Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.6          Sublingual Drug Delivery Market

7.5.6.1      Overview

7.5.6.2      Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.7          Rectal Transmucosal Drug Delivery Market

7.5.7.1      Overview

7.5.7.2      Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.5.8          Vaginal Transmucosal Drug Delivery Market

7.5.8.1      Overview

7.5.8.2      Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.6            Topical drug delivery Market

7.6.1          Overview

7.6.2          Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.6.3          Semi-solid Topical Drug Delivery Formulations Market

7.6.3.1      Overview

7.6.3.2      Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)

7.6.4          Liquid Topical Drug Delivery Formulations Market

7.6.4.1      Overview

7.6.4.2      Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)

7.6.5          Solid Topical Drug Delivery Formulations Market

7.6.5.1      Overview

7.6.5.2      Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)

7.6.6          Transdermal Patches Market

7.6.6.1      Overview

7.6.6.2      Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)

7.6.7          Transdermal Gels Market

7.6.7.1      Overview

7.6.7.2      Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)

7.6.8          Others Market

7.6.8.1      Overview

7.6.8.2      Others Market Revenue and Forecast to 2027 (US$ Mn)

7.7            injectable drug delivery Market

7.7.1          Overview

7.7.2          Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.7.3          Conventional Injection Devices Market

7.7.3.1      Overview

7.7.3.2      Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)

7.7.4          Self-Injection Devices Market

7.7.4.1      Overview

7.7.4.2      SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)

7.7.4.3      Needle Free Injectors Market

7.7.4.3.1       Overview

7.7.4.3.2       Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)

7.7.4.4      Pen injectors Market

7.7.4.4.1       Overview

7.7.4.4.2       Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)

7.7.4.5      Wearable Injectors Market

7.7.4.5.1       Overview

7.7.4.5.2       Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)

7.8            Implantable drug delivery Market

7.8.1          Overview

7.8.2          Implantable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.8.3          Active Implantable Market

7.8.3.1      Overview

7.8.3.2      Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)

7.8.4          Passive Implantable Market

7.8.4.1      Overview

7.8.4.2      Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)

7.9            ocular drug delivery Market

7.9.1          Overview

7.9.2          Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.9.3          Eye Drops and Sprays Market

7.9.3.1      Overview

7.9.3.2      Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)

7.9.4          Gels & Ointments Market

7.9.4.1      Overview

7.9.4.2      Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)

7.9.5          Ocular Inserts Market

7.9.5.1      Overview

7.9.5.2      Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)

7.9.6          Drug Coated Contact Lens Market

7.9.6.1      Overview

7.9.6.2      Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)

PART 8.       North America Drug delivery systems market Analysis – By Application

8.1            Overview

8.2            NORTH AMERICA drug delivery systems MARKET, BY application, 2018 & 2027 (%)

8.3            North America Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.4            homecare Settings market

8.4.1          Overview

8.4.2          North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)

8.5            hospitals & clinics Market

8.5.1          Overview

8.5.2          North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

8.6            others Market

8.6.1          Overview

8.6.2          North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

PART 9.       North America Drug delivery systems market Analysis – By Distribution Channel

9.1            Overview

9.2            NORTH AMERICA Drug delivery systems MARKET, BY distribution channel, 2018 & 2027 (%)

9.3            North America Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.4            hospital pharmacies market

9.4.1          Overview

9.4.2          North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.5            retail pharmacies market

9.5.1          Overview

9.5.2          North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.6            online pharmacies market

9.6.1          Overview

9.6.2          North America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

PART 10.    north america drug delivery market

10.1.1       Overview

10.1.2       North America Drug Delivery Market Revenue And Forecasts to 2027 (US$ Mn)

10.1.3       North America Drug Delivery Market Revenue And Forecasts to 2027, By Route Of Administration  (US$ Mn)

10.1.3.1    North America Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.2    North America Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.3    North America Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.4    North America Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.4.1    North America Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.5    North America Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.6    North America Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.7    North America Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.8    North America Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.4       North America Drug delivery market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.5       North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.6       North America Drug delivery Market Revenue and Forecasts to 2027, By Country (%)

10.1.7       US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8       US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1    US Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

10.1.8.1.1    US Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.2    US oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.3    US Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.4    US Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.4.1        US Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.5    US Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.6    US Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.7    US Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.1.8    US Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.2    US Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.8.3    US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.9       Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10     Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10.1 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

10.1.10.1.1 Canada Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.2 Canada Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.3 Canada Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.4 Canada Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.5 Canada Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.6 Canada Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.7 Canada Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.8 Canada Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.1.9 Canada Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.2 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.10.3 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.11     Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

10.1.12     Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

10.1.12.1 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

10.1.12.1.1 Mexico Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.2 Mexico Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.3 Mexico Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.4 Mexico Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.5 Mexico Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.6 Mexico Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.7 Mexico Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.8 Mexico Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.1.9 Mexico Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.2 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.12.3 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

PART 11.    drug delivery systems market – Industry Landscape

11.1         Overview

11.2         Comparative Company Analysis

11.3         Growth Strategies done by the companies in the Market, (%)

11.4         Organic Developments

11.4.1       Overview

11.5         Inorganic developments

11.5.1       Overview

PART 12.    Drug delivery systems market – Key company profiles

12.1         3M

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Financial Overview

12.1.4       Product Portfolio

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2         BD

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Financial Overview

12.2.4       Product Portfolio

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3         Boston Scientific Corporation

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Financial Overview

12.3.4       Product Portfolio

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4         novo nordisk a/s

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Financial Overview

12.4.4       Product Portfolio

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5         Bausch Health Companies Inc.

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Financial Overview

12.5.4       Product Portfolio

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6         BAxter International, Inc.

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Financial Overview

12.6.4       Product Portfolio

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7         Boehringer Ingelheim International GmbH

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Financial Overview

12.7.4       Product Portfolio

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8         Novartis AG

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Financial Information

12.8.4       Product Portfolio

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9         GlaxoSmithKline plc.

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Financial Overview

12.9.4       Product Portfolio

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10      Terumo Corporation

12.10.1     Key Facts

12.10.2     Business Description

12.10.3     Financial Overview

12.10.4     Product portfolio

12.10.5     SWOT ANALYSIS

12.10.6     KEY DEVELOPMENTS

12.11      Johnson & Johnson Services, Inc.

12.11.1     Key Facts

12.11.2     Business Description

12.11.3     Financial Overview

12.11.4     Product Portfolio

12.11.5     Swot Analysis

12.11.6     Key Developments

PART 13.    Appendix

13.1         About The Insight Partners

13.2         Glossary of Terms

13.3         Methodology

13.3.1       Coverage

13.3.2       Secondary Research

13.3.3       Primary Research

LIST OF TABLES

TABLE 1.           North America Drug delivery systems market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

TABLE 2.           North America Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 3.           North America drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 4.           North America Drug delivery market Revenue And Forecasts to 2027, By route of administration (US$ Mn)

TABLE 5.           North America Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 6.           North America oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 7.           North America Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 8.           North America Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 9.           North America Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 10.        North America topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 11.        North America nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 12.        North America Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 13.        North America Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 14.        North America Drug delivery market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 15.        North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 16.        US Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

TABLE 17.        US Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 18.        US oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 19.        US Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 20.        US Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 21.        US Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 22.        US topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 23.        US nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 24.        US Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 25.        US Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 26.        US Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 27.        US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

TABLE 28.        Canada Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

TABLE 29.        Canada Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 30.        Canada oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 31.        Canada Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 32.        Canada Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 33.        Canada Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 34.        Canada topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 35.        Canada nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 36.        Canada Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 37.        Canada Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 38.        Canada Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 39.        Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 40.        Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

TABLE 41.        Mexico Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 42.        Mexico oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 43.        Mexico Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 44.        Mexico Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 45.        Mexico Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 46.        Mexico topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 47.        Mexico nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 48.        Mexico Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 49.        Mexico Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 50.        Mexico Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 51.        Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 52.        Organic Developments Done By Companies

TABLE 53.        Inorganic developments done by Companies

TABLE 54.        Glossary of Terms, Drug delivery systems market

 

LIST OF FIGURES

FIGURE 1.        US Drug delivery systems market, Revenue (US$ Mn), By COuntry 2018 & 2027

FIGURE 2.        north America drug delivery systems Market By Route of Administration, Market Share (%), 2018

FIGURE 3.        north America drug delivery systems Market By Application, Market Share (%), 2018

FIGURE 4.        North America Drug delivery systems Market By Distribution Channel, Market Share (%), 2018

FIGURE 5.        Drug delivery systems market Segmentation

FIGURE 6.        North America PEST Analysis

FIGURE 7.        Drug delivery systems market impact analysis of drivers & Restraints

FIGURE 8.        North America Drug delivery systems market – Revenue Forecasts and Analysis – 2018- 2027

FIGURE 9.        North America drug delivery systems market, By Route of Administration, 2018 & 2027 (%)

FIGURE 10.     Oral Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 11.     transmucosal Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 12.     IN-METERED DOSE INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 13.     DRY POWDER INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 14.     NEBULIZERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 15.     NASAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 16.     NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 17.     NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 18.     NASAL GEL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 19.     BUCCAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 20.     SUBLINGUAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 21.     RECTAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 22.     VAGINAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 23.     topical Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24.     SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 25.     LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 26.     SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 27.     TRANSDERMAL PATCHES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 28.     TRANSDERMAL GELS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 29.     OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 30.     injectable Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 31.     CONVENTIONAL INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 32.     SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 33.     NEEDLE FREE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 34.     PEN INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 35.     WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 36.     Implantable drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37.     ACTIVE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 38.     Passive Implantable MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 39.     Ocular drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 40.     Eye Drops And Spray MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 41.     Gels & Ointments MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 42.     Ocular Inserts MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 43.     Drug Coated Contact Lens MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 44.     North America drug delivery systems market By application, 2017 & 2025 (%)

FIGURE 45.     North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46.     North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 47.     North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 48.     North America drug delivery systems market By distribution channel, 2018 & 2027 (%)

FIGURE 49.     North America HOSPITAL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 50.     North America RETAIL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 51.     North America online PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52.     North America Drug delivery market revenue Overview, by Country (2018) (us $ mn)

FIGURE 53.     North America Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 54.     North America Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)

FIGURE 55.     US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 56.     Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 57.     Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 58.     Comparative Company Analysis

FIGURE 59.     Growth Strategies done by the companies in the Market, (%)

 

The List of Companies

1. BD
2. Novo Nordisk A/S
3. 3M
4. Boston Scientific Corporation
5. Bausch Health Companies Inc.
6. Baxter International, Inc.
7. Boehringer Ingelheim
8. Novartis AG
9. GlaxoSmithKline plc.
10. Johnson & Johnson Services, Inc.
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2019 - The Insight Partners. All rights reserved